(Q37755142)

22 August 2017

title

Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity (English)

1 reference

22 August 2017

0 references

0 references

1 reference

3

Gavin Giovannoni

1 reference

22 August 2017

1

Charlotte E Teunissen

1 reference

22 August 2017

2

Joep Killestein

1 reference

22 August 2017

publication date

1 June 2007

1 reference

22 August 2017

published in

Biomarkers in Medicine

1 reference

22 August 2017

volume

1

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

111-119

1 reference

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Immunopathogenesis and immunotherapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

New antigenic candidates in multiple sclerosis: identification by serological proteome analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Neurofilament proteins in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Acute axonal damage predicts clinical outcome in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Axonal degeneration and inflammation in acute optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Cerebrospinal fluid levels of brain specific proteins in optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Axonal damage and outcome in subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

24S-Hydroxycholesterol: a Marker of Brain Cholesterol Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Development of biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Multiple sclerosis cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

Mitochondrial Protein Nitration Primes Neurodegeneration in Experimental Autoimmune Encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.1.111

21 January 2018

Identifiers

DOI

10.2217/17520363.1.1.111

1 reference

22 August 2017

1 reference